Efficacy of manualized short-term psychodynamic therapy for separation anxiety disorder, generalized anxiety disorder and social anxiety disorder in children

Efficacy of manualized short-term psychodynamic therapy for separation anxiety disorder, generalized anxiety disorder and social anxiety disorder in children: a randomized controlled multicenter trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN11333815

Enrollment

174

Registered

2014-11-20

Start date

2014-11-24

Completion date

Unknown

Last updated

2015-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety disorders in children (separation anxiety disorder, generalized anxiety disorder, social anxiety disorder) Mental and Behavioural Disorders Separation anxiety disorder of childhood, generalized anxiety disorder, social anxiety disorder of childhood

Interventions

Manualized psychodynamic short-term psychotherapy versus waiting list condition (16 weeks)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Primary diagnosis of separation anxiety disorder, generalized anxiety disorder or social anxiety disorder according to DSM-IV/-5 2. Aged 7 to 13 years old

Exclusion criteria

Exclusion criteria: 1. Psychotic disorders 2. Substance-related disorders 3. Organic mental disorders 4. Severe medical conditions 5. IQ ? 80 6. Post-traumatic stress disorder (PTSD) 7. Severe attention deficit hyperactivity disorder (ADHD) 8. Suicidal ideation 9. Concurrent psychotherapeutic or psychopharmacological treatment

Design outcomes

Primary

Measure	Time frame
Response defined as at least 30% reduction of ADIS-C/P-IV CSR ratings for the primary diagnosis or ADIS-C/P CSR =3 rating for the primary diagnosis (ADIS-C/P) (Silverman & Albano, 2008) by trained experts unaware of group assignment. Primary outcomes are measured at baseline, after 2, 4, 8, 12 and 16 months (and additionally after 20 months for patients from the waiting list).	—

Secondary

Measure	Time frame
1. Rates of remission 2. CGI 3. TAI-R-K or SPAIK or PSWQ-K (dependent on primary diagnosis) 4. SCARED 5. SDQ 6. DIKJ 7. Familienboegen 8. FTB 9. EQ-5D-Y for children Secondary outcomes are measured at baseline, after 2, 4, 8, 12 and 16 months (and additionally after 20 months for patients from the waiting list).	—

Countries

Germany

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026